Urinary Podocyte Biomarkers and Glomerular Histologic Change
- 31 March 2022
- journal article
- editorial
- Published by Wolters Kluwer Health in Kidney360
- Vol. 3 (3) , 407-409
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Relationships between Levels of Urinary Podocalyxin, Number of Urinary Podocytes, and Histologic Injury in Adult Patients with IgA NephropathyClinical Journal of the American Society of Nephrology, 2012
- Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxinDiabetologia, 2012
- Urinary Podocyte-Associated mRNA profile in Various Stages of Diabetic NephropathyPLOS ONE, 2011
- Urine Podocyte mRNAs Mark Progression of Renal DiseaseJournal of the American Society of Nephrology, 2009
- Podocyte Depletion Causes GlomerulosclerosisJournal of the American Society of Nephrology, 2005
- Urinary Podocyte Loss Is a More Specific Marker of Ongoing Glomerular Damage than ProteinuriaJournal of the American Society of Nephrology, 2005
- Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuriaMetabolism, 2001
- Effects of Angiotensin-Converting Enzyme Inhibitor, Angiotensin II Receptor Antagonist and Calcium Antagonist on Urinary Podocytes in Patients with IgA NephropathyAmerican Journal of Nephrology, 2000
- Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathiesKidney International, 1998
- Proteinuria and Progression in Human Glomerular DiseasesAmerican Journal of Nephrology, 1990